chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she had a PCR test before taking the 2nd dose vaccine and she got a result this morning after she took the 2nd dose vaccine and she is positive in covid 19; she is positive in covid-19; This is a Spontaneous report from a contactable consumer (Patient herself) via Pfizer program. A female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: Not reported, Expiry date: Not reported) via an unspecified route of administration 04Apr2021 at SINGLE DOSE for COVID-19 Immunization. The patients medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: Not reported, Expiry date: Not reported) via an unspecified route of administration 10Mar2021 at SINGLE DOSE for COVID-19 Immunization. The patient got the 1st dose 10Mar2021 and got the 2nd dose on 04Apr2021. She had a PCR test before taking the 2nd dose vaccine and she got a result this morning after she took the 2nd dose vaccine and she is positive in covid 19. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Based on
Pale, clammy, achy all over, shaky, cough, throat felt like cotton, exhausted 24 hrs later. Blood shot eyes.
Information has been received from a psychologist concerning her 18 month old daughter with no pertinent medical history or drug reactions who on 16-OCT-2006 was vaccinated with Hib conj vaccine (OMPC)(manufacturer unknown, reported as "Hib" vaccine). Concomitant therapy included diphtheria toxoid (+) pertussis vaccine (unspecified) (reported as "DTP"). The reporter did not know the manufacturer or the brand name of the vaccines. After the patient received the vaccines, she started to look "vacant" and developed fever and became listless on 16-OCT-2006. The next day she had the fever of 104 and cried non stop along with motor tic. She went to an emergency room but later released. She continued to have the fever for 5 days. The fever was resolved and he started to talk again on the sixth day. All the symptoms had disappeared except some occasional tic. Additional information has been requested.
Received shots then discharged from clinic, in parking lot suddenly threw up, then complained of chest hurting. Back in clinic, eyes and face were red, slight face swelling then began scratching. Injection site of MMRV had 2cm redness and 4mm whelp. Other sites were clear. Required albuterol, Orapred and Benadryl. Discharged 1.5hrs later.
Patient given vaccine scheduled for 5-11 year old. Pt is 12 year, 1 month old. Patient had no adverse effects and tolerated vaccine well.
I had blood clots in my lungs I had a CT scan with contrast and without contrast I also had blood work I had a thrombectomy to me to remove the pulmonary embolism.
Information has been received from a nurse practitioner concerning a patient who on 17-DEC-2007 was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant therapy given that same day included measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process). The nurse reported the incident was due to human error, there was no product confusion. The patient did not experience any known symptoms. There was no product quality complaint. Additional information is not expected. Further information has been received from the nurse practitioner regarding this four year old female who was vaccinated on 17-DEC-2007 with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (Lot # 654893/1029F) SQ in the right quad (second dose) and secondary suspect therapy included measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (Lot # 656894/0917U) first dose in the right quad. Additional concomitant vaccines included Hepatitis A (GSK) lot# AHAVB182AA IM right quad, DTAP (GSK) lot # ac14B051AA, IM left quad, IPV (SANOFI) Lot # A0169 SQ left quad and FLU vaccine (SANOFI) lot # U2513AA, IM left quad. It was reported that the patient was not seen within 48 hours of vaccination. On 21-DEC-2007 the patients father stated there was no adverse event, only mild tenderness to both legs with mild fatigue. The patients mother stated on 15-JAN-2008 that "there was no adverse side effects except for mild pain at the site for two or three days."
This spontaneous report was received from a registered nurse referring to male patient of unknown age. The patient's relevant medical history, drug reactions/allergies and concomitant medication were not reported. On an unknown date, the patient was vaccinated with GARDASIL or GARDASIL 9 for prophylaxis (strength, dose, units and lot number were not reported). The nurse stated that she knew a coworker's grandson that became more laid back and had behavior changes after being vaccinated. It was unknown by the reporter which of the two vaccines were administered to the patient. The outcome of the events was unknown. Causality assessment was not provided. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1710USA007114.
pt recv vax 25JUL95 & 10DEC96 pt devel a breakthrough case of chicken pox consisting of approx 200 lesions on back, face, arms & legs;
Diarrhea; Sweating in the middle of the night like someone pour a glass in bed; High body temperature but the temperature was not consistent and eventually went away; Severe pain from the bones and muscle; Shivering at night; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating in the middle of the night like someone pour a glass in bed), PYREXIA (High body temperature but the temperature was not consistent and eventually went away), MYALGIA (Severe pain from the bones and muscle) and CHILLS (Shivering at night) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating in the middle of the night like someone pour a glass in bed), PYREXIA (High body temperature but the temperature was not consistent and eventually went away), MYALGIA (Severe pain from the bones and muscle) and CHILLS (Shivering at night). At the time of the report, DIARRHOEA (Diarrhea), HYPERHIDROSIS (Sweating in the middle of the night like someone pour a glass in bed), PYREXIA (High body temperature but the temperature was not consistent and eventually went away), MYALGIA (Severe pain from the bones and muscle) and CHILLS (Shivering at night) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant products usage were not reported by the reporter.  No treatment medication were reported.
Vaccinated 8 yr old - Appeared fine while vaccinated - at cashiers door - fainted on floor. Brought in by aunt.
HAD DTaP AND OTHER VACCINES ON 8/16/05.  8/18/2005 AM MOC DRESSING SON NOTICED LEFT ARM (DELTOID0 RED, SWOLLEN WITH DISCOMFORT.  MOC BROUGHT CHILD TO PUBLIC HEALTH.  EXPLAINED CAN HAPPEN ON 4TH OR 5TH DTaP.  MOM REASSURED.
Provider d/c summary note:  "Case of a 64 y/o female with PMHx of ETOH use disorder, Anxiety, Depression, COPD who is presenting to the ED for evaluation of GLF. Patient presented to WV ED after having a mechanical fall and twisted her left ankle. Patient was sent for orthopedic surgery management. X-ray showed comminuted fracture of the proximal fibular diaphysis and Spiral fracture through the distal tibial diaphysis. Orthopedic surgery was consulted. An intramedullary nailing of left tibia-fibula shaft fracture using synthesis tibial nail was performed. Pain was managed with norco and tylenol. PT and OT were consulted. Patient remained non-weight bearing in the left leg. Patient complained of persistent pain in the left leg. Ortho change pain medication to percocet and fentanyl. Patient had persistent persistent pain in the left leg difficult to control. However, the leg was frequently monitored by ortho showing no signs of any post surgical complications. Leg pain began slowly improving and fentanyl was weaned off. Patient was going to be discharged to SNF when covid test came back positive.  Patient with coughm decreased oxygen saturation and wheezing. Was diagnosed with acute respiratory failure due to covid. Patient needed supplemental oxygen. Patient was given remdesivir and decadron. Was given albuterol PRN, Symbicort and duonebs. Patient remained in hospital for 10 days as per covid (+) protocol. Pain of the leg was controlled, cough and wheezing improved. Patient was weaned off of oxygen. Patient discharged to Caretel SNF with Ortho follow up on 08/30/2022."
Diarrhea on 13th and 14th. No treatment.  Reporting this as diarrhea continues.  No hospitalization required at this time.
Right upper arm, circles entire UA, hand/warm/painful. Pain from above elbow into right shoulder-movement limited
Patient flu shot 11/16/2006 on LD.  Patient reports 11/17/06 left arm was swollen at the injection site.  Are was red and warm and "the size of her hand".  Patient reports running fever but did not take temp.  Patient reports "top part of stomach felt like it was on fire".  Patient reports " passing out" around 7pm that evening.  Patient called to report symptoms on 11/21/06 and reports feeling fine today.
Initial information received on 04-Feb-2019 regarding an unsolicited valid non-serious case received from a physician via other company (Pfizer). This case involves a patient who experienced drug allergies diphth- acell pertussis- tetanus, while he/she received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE. The patient's past medical history included Drug Allergies including Codeine; Iodinated Diagnostic Agents. On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot number, expiry date not reported via unknown route in unknown administration site. On an unspecified date, the patient developed a non-serious allergy to diphth- acell pertussis- tetanus (drug allergy to vaccine) (unknown latency) following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE. Lab data not reported. Final diagnosis was allergy to diphth- acell pertussis- tetanus. It was not reported if the patient received a corrective treatment. The event outcome was not reported. List of document held by sender: none.
Shortly after getting the 2nd vaccine I started getting "pox" like bumps on my back. Maybe a few a week.  On 10/27/2021 I started taking a blood thinner (Xeralto) and almost immediately started getting more bumps on my back several a day - itching and some pain.  It is not shingles.  On 11/29 I noticed one of the "pox" on the middle of my tongue and the skin around it started turning black. At 10pm on 12/30 my tongue swelled up so much that I had a hard time breathing and talking. The tongue black and purple. Went to the ER and my BP was over 200. Was given 4-factor KCENTRA to reverse the blood thinner.  Was also given BP meds to lower the BP.  By about 6 AM the swelling was done some and the BP stable. I've been told that it "may be" that the vaccine changed something in my body to make me now allergic to that blood thinner.  I will be off the blood thinner for 12 days. Don't know if my doctor will put me on Plavix then.  I do not have an actual diagnosis of the "pox" on my body.
8-14-2018 6:30 pm achy Lt. arm painful - no redness; 7:00 pm achy cheekbones in face painful extreme pain Lt. arm: unable to move arm. At inj site no redness; 8:00 pm same but more pain (L) arm low grade fever 99. Took 2 extra strength TYLENOL at 9 pm went to bed; 9:00 am 8-15 woke up achy, cheekbones hurt, Lt arm unable to lift due to severe pain. No redness at inj. site. 6 pm arm (L) still painful to lift. Less achy 10 pm pain (L) arm to lift slight achy. 11 pm to bed. 9 am 8-16 not achy arm (L) able to lift more. 1/2 the pain. (L) arm painful and lifting arm less painful. By 8-19 Sun. (L) arm no pain. The pain in (L) arm I never experienced before. When I have my first PNEUMONIA (5-9-2017) inj. I experienced no pain or any reaction.
6 days of difficulty breathing. Daily inhaler and rescue inhaler did not seem to relieve the inflammation that made it difficult to breathe. Day 7 after vaccine, I woke up and the difficulty breathing had resolved.
This spontaneous report as received from a Nurse Practitioner refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with a dose of PROQUAD injection (dose, route of administration, lot # and expiration date were not reported) rather than a dose of M-M-R II (dose, route of administration, lot # and expiration date were not reported). No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
No additional AEs; HCP reported that a 28 year old patient received their second dose of GARDASIL 9 before the 2 month mark. HCP reports the patient received their first dose on 3/13/23 and second dose on 4/17/23. No further information was provided to further clarify; This spontaneous report was received from a pharmacist concerning a 28-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 13-MAR-2023, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) administered for prophylaxis (dose, strength, lot #, expiry date, anatomical location and route of administration were not provided). On 17-APR-2023, the patient received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), which was before the 2 months mark (Inappropriate schedule of product administration). No adverse event was reported.
Tinnitus began approximately 15May and is persistent mild to moderate in nature, it is not exacerbated or relieved by anything.  The severity of the tinnitus is increasing and is currently not resolved.; severe fatigue; myalgias; headache; fever; occasional rigors; The tender lymphadenopathy of the left clavicular area recurred 01May and resolved by 15May; This is a spontaneous report from a contactable other healthcare professional. A 51 year old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 30Apr2021 (Batch/Lot Number: ER8735) as DOSE 2, SINGLE for covid-19 immunisation. Historical vaccine included bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 08Apr2021 (Batch/Lot Number: ER8737) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing. Concomitant medication(s) included lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported. The patient experienced severe fatigue on 01May2021 with outcome of not recovered, myalgias on 01May2021 with outcome of not recovered, headache on 01May2021 with outcome of not recovered, fever on 01May2021 with outcome of not recovered, occasional rigors and chills on 01May2021 with outcome of not recovered, the tender lymphadenopathy of the left clavicular area recurred on 01may and resolved by 15may on 01May2021 with outcome of recovered, tinnitus began approximately on 15may and is persistent mild to moderate in nature, it is not exacerbated or relieved by anything.  the severity of the tinnitus is increasing and is currently not resolved on 15May2021 with outcome of not recovered.    Follow-up (23Aug2021): Follow-up attempts are completed. No further information is expected.
hx given by father; vax given 12AUG92 on 20AUG92 pt had temp of 102; on 22AUG92 pt had eye & lid twitching & unusual grimmacing;
Information has been received from a consumer concerning her 71 year old husband with no known allergies and a history of aortic valve replacement (pig valve) in December 2003, a normal echocardiogram in December 2006 and a flu vaccine (dates and manufacturer not specified) who on 11-APR-2007 was vaccinated with ZOSTAVAX (#656859/0357U) in his left arm. Concomitant therapy included aspirin. The consumer reported that she and her husband "RV" and they were an active energetic couple that liked to hike. On 31-OCT-2007 the patient developed shortness of breath, angina, tightness and pressure in his chest. An EKG performed indicated that a blockage was developing. This blockage triggered an overall heart weakness. On 02-NOV-2007, a heart chemical stress test was done (no results reported) and on 03-DEC-2007, another echocardiogram was done (no results reported). On 12-DEC-2007, an angiogram was done (no results reported). On 22-JAN-2008, an MRI revealed the overall weakness of the patient's heart. On 22-JAN-2008 and 23-JAN-2008, the patient wore a Holter Monitor (no results reported). On 12-FEB-2008, the patient experienced chest pressure and was admitted to the hospital via ambulance. On 14-FEB-2008, a heart chemical stress test and angioplasty were done. Two stents were placed to the left anterior descending artery. The patient was placed on increasing doses of COREG in addition to LASIX, PLAVIX, aspirin, simvastatin and COUMADIN. The patient was told that a live virus caused the weakness in his heart. The patient was diagnosed with cardiomyopathy, cardiomegaly and congestive heart failure. He was discharged from the hospital on 16-FEB-2008. As of 06-MAR-2008, the patient had not recovered. There was discussion as to whether the patient would need a possible pacemaker or defibrillator. The consumer felt that her husband's heart problems may have been related to the ZOSTAVAX. She noted that the previous flu shot was ruled out in causing the weakness of his heart. Additional information is not expected. 5/19/08-records received from cardiologist. 10/31/07-presented with C/O chest discomfort with dull ache in left chest area for past 3 nights. Recently began exercising using a stationary bike and developed chest pain 10-15 minutes into exercises.1/16/08-seend for C/O chest pain lightheadedness, peripheral edema. Left ventricular dysfunction with totally occluded right coronary artery. Stenting of LAD. Ischemic and nonischemic cardiomyopathy. 06/9/08-records received-3/13/07-office visit continues to see neurologist regarding peripheral neuropathy which is status quo.
Redness; itchy; Skin warm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PRURITUS (itchy) and SKIN WARM (Skin warm) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ERYTHEMA (Redness), PRURITUS (itchy) and SKIN WARM (Skin warm). At the time of the report, ERYTHEMA (Redness), PRURITUS (itchy) and SKIN WARM (Skin warm) had resolved.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not Applicable.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Additional information received on 12-May-2021 as Adverse Events outcome was updated.
1 1/2 day p/immun given, pt had screaming constant, inconsolable crying 2 1/2-3 hrs in duration; no comfort worked; while was screaming, legs & arms were shaking, had trouble catching breath; t>101; pt recvd DT next time;
Since my vaccine I am experiencing pain at injection site but with no redness there or swelling, hives /itchy rash on my torso/legs/arms/ and night sweats and intermittent blurry vision. Body aches but had them before vaccine. Slightly elevated heart beat at night sometimes when on my left side, intermittent upset tummy, and interrupted sleep pattern. Started 2/3 days post vaccine and as of today still have it. What should I do?
Swelling of upper right arm and localized swelling on back of right arm between injection sites. Warmth, erythema in circle on back of right arm about 4 inches in diameter. Itching.
pt eyes swollen almost shut; raised rash on abdo referred to PMD; pt had asthma attack later 18APR94;
On 9/30/99, the infant developed intussusception. No further information was available at the date of this report. Intussusception is considered medically important.
Short term memory loss, tiredness quickly exhausted when doing activities, weight gain with same food intake, hair loss.
This spontaneous report as received from a nurse practitioner referring to a 18 year old patient of unknown gender. The patient's medical history, drug reactions/allergies and concomitant medications were not provided. On an unknown date in 2012, the patient was vaccinated with the first dose of GARDASIL for prophylaxis (route, lot# and expiry date were unknown). On an unknown date in 2013, the patient was vaccinated with the second dose of GARDASIL for prophylaxis (route, lot# and expiry date were unknown); possibly not following the prescribing schedule. No adverse effects were reported.
On set almost exactly 12 hours later. Fever of 100.0 F, chills, nausea, general muscle discomfort, soreness at injection site.
PATIENT RECEIVED PNEUMOVAX ON 10/23/2006.  SHE EXPERIENCED HIVES AROUND INJECTION SITE, REDNESS, TENDERNESS, AND SORENESS ON 10/25/2006.  ON 10/26/2006, SHE EXPERIENCED A FLAT, RED RASH ON HER CHEST AND BREASTS.  SHE HAS BEEN TAKING BENADRYL WHICH HAS DECREASED THE SYMPTOMS.
gastro problems; This spontaneous case was reported by a patient and describes the occurrence of GASTROINTESTINAL DISORDER (gastro problems) in a 74-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GASTROINTESTINAL DISORDER (gastro problems). At the time of the report, GASTROINTESTINAL DISORDER (gastro problems) outcome was unknown. Not Provided      For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug information was provided.  Patient explained that he was super fit and had done sports all his life. People won't believe him when he told them he was 74.  No treatment medications were reported.   This case was linked (Patient Link).
17 yo patient received Pfizer 5-11 COVID vaccine instead of Pfizer 12+ vaccine.  no additional doses were given.  patient was advised per agency website to return in 21 days for a Pfizer 12+ vaccine.